Long-term effect of fingolimod on cardiovascular functioning in people with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Haase, R. [1 ]
Forberger, C. [1 ]
Schilling, M. [1 ]
Piatkowski, F. [1 ]
Akgun, K. [1 ]
Rudiger, H. [1 ]
Ziemssen, T. [1 ]
机构：
[1] Univ Hosp Carl Gustav Carus Dresden, Dept Neurol, Ctr Clin Neurosci, Dresden, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P726
引用
收藏
页码：609 / 610
页数：2
相关论文
共 50 条
  • [1] Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with Relapsing-Remitting Multiple Sclerosis
    Cohen, Jeffrey
    Tenenbaum, Nadia
    Bhatt, Alit
    Pimentel, Ron
    Kappos, Ludwig
    NEUROLOGY, 2017, 89 (08) : E103 - E103
  • [2] The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis
    Derfuss, T.
    Sastre-Garriga, J.
    Montalban, X.
    Rodegher, M.
    Wuerfel, J.
    Gaetano, L.
    Tomic, D.
    Azmon, A.
    Wolf, C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (01)
  • [3] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [4] Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence
    Khatri, Bhupendra O.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (02) : 130 - 147
  • [5] Long-term Effect of Fingolimod in Reducing Blood Neurofilament Light Levels in Patients with Relapsing-remitting Multiple Sclerosis
    Cohen, Jeffrey
    Kappos, Ludwig
    Tenenbaum, Nadia
    Han, Jackie
    Kropshofer, Harald
    Tomic, Davorka
    Kuhle, Jens
    NEUROLOGY, 2019, 92 (15)
  • [6] Oral fingolimod for relapsing-remitting multiple sclerosis
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
  • [7] Long-term outcome of minocycline in relapsing-remitting multiple sclerosis
    Zhang, Y.
    Metz, L. M.
    Yong, V. W.
    Bell, R. B.
    Yeung, M.
    Patry, D.
    Mitchel, J. R.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1226 - 1226
  • [8] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 640 - 640
  • [9] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    SWISS MEDICAL WEEKLY, 2016, 146 : 80S - 80S
  • [10] Long-term effect of natalizumab in relapsing-remitting multiple sclerosis: TYSTEN cohort
    Bigaut, K.
    Fabacher, T.
    Kremer, L.
    Ongagna, J. -C.
    Kwiat-Kowski, A.
    Sellal, F.
    Ferriby, D.
    Courtois, S.
    Vermersch, P.
    Collongues, N.
    Zephir, H.
    De Seze, J.
    Outteryck, O.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 536 - 536
12345